Prosperity of community pharmacy evaluated by gross and net profit and suggested corrective measures. 10 years study / Prosperita verejnej lekárne hodnotená prostredníctvom hrubého a čistého zisku a opatrenia vedúce k ich náprave. 10 ročná štúdia

Malovecká, I.; Papargyris, K.; Mináriková, D.; Foltán, V.; Jankovská, A.

doi:10.1515/afpuc-2015-0015

Abstract

Monitoring, calculation and assessment of community pharmacy prosperity with the help of financial analysis indicators for years 2003-2012, using financial statements was conducted, with respect to profitability parameters such as gross and net profit ratios. These ratios reflect various changes that hold between years 2003 and 2012. Under the time of financial crisis, recession and serious socioeconomic changes the profitability parameter gross profit ranged from x_2003-2011=14.3-22.8% (average=19.2%, mean=19.8%, σ=2.4), but in 2012 decreased on 14.3%. Net profit ranged x_2003-2011 = 2.3-18.3% (average=14.6%, mean =16.6%, σ = 4.9), while in 2012 reached only 2.3%. All changes that have taken place in the society had impact on community pharmacy finance by worsening its profitability. Therefore, the stability of community pharmacy may be threatened and may affect its future performance.

References

[1] Cheng Y, Raisch D W, Borrego ME, Gupchup GV. Research in Social and Administrative Pharmacy, 9(3), 2013, 311-329.10.1016/j.sapharm.2012.05.00422835704
Search in Google Scholar
[2] Ifanti AA, Argyriou AA, Kalofonou FH, Kalofonos HP. Financial crisis and austerity measures in Greece: Their impact on health promotion policies and public health care. Health Policy, 113 (1-2), 2013, 8-12.10.1016/j.healthpol.2013.05.01723790265
Search in Google Scholar
[3] Goranitis I, Siskou O, Liaropoulos L. Health policy making under information constraints: An evaluation of the policy responses to the economic crisis in Greece. Health Policy, Accepted Manuscript, Available online 1 August 201410.1016/j.healthpol.2014.07.01225150026
Search in Google Scholar
[4] Markovits Y, Boer D, van Dick R. Economic crisis and the employee: The effects of economic crisis on employee job satisfaction, commitment, and self-regulation. European Management Journal, 32 (3), 2014, 413-422.10.1016/j.emj.2013.09.005
Search in Google Scholar
[5] Jacobs S, Schafheutle EI, Jee SD, Elvey R, Hassell H, Noyce PR. Existing arrangements for monitoring community pharmacies in England: Can they have a role in the revalidation of pharmacists? Research in Social and Administrative Pharmacy, 9(2), 2013, 166-177.10.1016/j.sapharm.2012.07.00623517658
Search in Google Scholar
[6] Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: Implications for service provision, the public health function, and pharmacy’s claims to professional status in the United Kingdom. Research in Social and Administrative Pharmacy, 5(4), 2009, 305-318.10.1016/j.sapharm.2009.01.00319962674
Search in Google Scholar
[7] McMillan SS, Wheeler AJ, Sav A, King MA, Whitty JA, Kendall E, Kell F. Community pharmacy in Australia: A health hub destination of the future. Research in Social and Administrative Pharmacy, 9(6), 2013, 863-875.10.1016/j.sapharm.2012.11.00323218552
Search in Google Scholar
[8] Keast SL, Jacobs E, Harrison D, Farmer K, Thompson D. Future economic outlook of Nebraska rural community pharmacies based on break-even analysis of community operational costs and county population. Research in Social and Administrative Pharmacy, 6(3), 2010, 209-220.10.1016/j.sapharm.2009.07.00320813334
Search in Google Scholar
[9] Norris P, Horsburgh S, Sides G, Ram, Fraser J. Geographical access to community pharmacies in New Zealand. Health & Place, 29(1), 2014, 140-145.10.1016/j.healthplace.2014.07.00525087053
Search in Google Scholar
[10] Perepelkin J, Dobson RT. Influence of ownership type on role orientation, role affinity, and role conflict among community pharmacy managers and owners in Canada. Research in Social and Administrative Pharmacy, 6(4), 2010, 280-292.10.1016/j.sapharm.2009.11.00121111386
Search in Google Scholar
[11] Carroll NC, Miederhoff PA, Waters LW. Profitability, third-party reimbursement, and access to community pharmacies. Clinical Therapeutics, 8(4), 1996, 703-715.10.1016/S0149-2918(96)80221-9
Search in Google Scholar
[12] Herist N, Rollins B, Perri M. Financial Analysis in Pharmacy Practice. London: Pharmaceutical Press; 2011.
Search in Google Scholar
[13] Burke S, Thomas S, Barry S, Keegan C. Indicators of health system coverage and activity in Ireland during the economic crisis 2008-2014 - From ‘more with less’ to ‘less with less’. Health Policy, In Press, Corrected Proof, Available online 17 July 201410.1016/j.healthpol.2014.07.00125082466
Search in Google Scholar
[14] Vogler S, Habimana K, Art D. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries. Health Policy, In Press, Corrected Proof, Available online 8 June 2014.10.1016/j.healthpol.2014.06.00124962537
Search in Google Scholar
[15] Matsaganis M, The Greek Crisis: Social Impact and Policy Responses, Department of Western Europe/North America, Berlin, 2013.
Search in Google Scholar
[16] de Belvis AG, Ferre F, Specchia MC, Valerio L, Fattore G, Ricciardi W. The financial crisis in Italy: Implications for the healthcare sector. Health Policy, 106(1), 2012, 10-16.10.1016/j.healthpol.2012.04.00322551787
Search in Google Scholar
[17] Ásgeirsdóttir TL, Corman H, Noonan K, Ólafsdóttir P, Reichman NE. Was the economic crisis of 2008 good for Icelanders? Impact on health behaviors. Economics & Human Biology, 13(1), 2014, 1-19.10.1016/j.ehb.2013.03.00523659821
Search in Google Scholar
[18] Sánchez-Serrano I. The World’s Health Care Crisis: The United States’ Leadership. The World’s Health Care Crisis, 2011, 3-28.10.1016/B978-0-12-391875-8.00001-9
Search in Google Scholar
[19] Söderberg IL, Wester M. Lay actions in the face of crisis-Swedish citizens’ actions in response to the global financial crisis of 2008. The Journal of Socio-Economics, 41(6), 2012, 796-805.10.1016/j.socec.2012.08.007
Search in Google Scholar
[20] Malovecká I, Mináriková D, Lehocká Ľ, Foltán V. New types of assessments of community pharmacy technology business and ther contribution towards prosperity of the community pharmacy. Acta Facultatis Pharmaceuticae Universitatis Comenianae. 2013, 60(1), 35-42.
Search in Google Scholar
[21] Smith M, Cannon-Breland ML, Spiggle S. Consumer, physician, and payer perspectives on primary care medication management services with a shared resource pharmacists network. Research in Social and Administrative Pharmacy, 10 (3), 2014, 539-553.10.1016/j.sapharm.2013.08.00324055137
Search in Google Scholar
[22] Radford A, Mason M, Richardson I, Rutledge S, Poley S, Mueller K, Slifkin R. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community. Research in Social and Administrative Pharmacy, 5(1), 2009, 17-30.10.1016/j.sapharm.2008.04.00419285286
Search in Google Scholar

Prosperity of community pharmacy evaluated by gross and net profit and suggested corrective measures. 10 years study / Prosperita verejnej lekárne hodnotená prostredníctvom hrubého a čistého zisku a opatrenia vedúce k ich náprave. 10 ročná štúdia

Abstract

Paradigm

My account